Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Antonio Gasbarrini; Massimo Siciliano

doi:10.1016/j.dld.2014.11.010

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Antonio Gasbarrini, Massimo Siciliano

Risultato della ricerca: Contributo in rivista › Articolo in rivista

5 Citazioni (Scopus)

Abstract

Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	Digestive and Liver Disease
DOI	https://doi.org/10.1016/j.dld.2014.11.010
Stato di pubblicazione	Pubblicato - 2014

Keywords

Early response
NS3 protease inhibitors
Viral kinetics
Virological failure

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.dld.2014.11.010

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{80ab057a324d403daaee1cdc018984f9,

title = "Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome",

abstract = "Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.",

keywords = "Early response, NS3 protease inhibitors, Viral kinetics, Virological failure, Early response, NS3 protease inhibitors, Viral kinetics, Virological failure",

author = "Antonio Gasbarrini and Massimo Siciliano",

year = "2014",

doi = "10.1016/j.dld.2014.11.010",

language = "English",

pages = "N/A--N/A",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "-Roma: Editrice Gastroenterologica Italiana. -Ospedaletto Pisa: Pacini",

}

TY - JOUR

T1 - Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

AU - Gasbarrini, Antonio

AU - Siciliano, Massimo

PY - 2014

Y1 - 2014

N2 - Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.

AB - Triple therapy with telaprevir/boceprevir+pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.

KW - Early response

KW - NS3 protease inhibitors

KW - Viral kinetics

KW - Virological failure

KW - Early response

KW - NS3 protease inhibitors

KW - Viral kinetics

KW - Virological failure

UR - http://hdl.handle.net/10807/63621

U2 - 10.1016/j.dld.2014.11.010

DO - 10.1016/j.dld.2014.11.010

M3 - Article

SN - 1590-8658

SP - N/A-N/A

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

ER -

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo